Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Indegene Limited ( (IN:INDGN) ) has issued an update.
Indegene Limited’s board has approved the appointment of Neeraj Bharadwaj as a Non-Executive Independent Director for a five-year term starting January 25, 2026, subject to shareholder approval via postal ballot. Bharadwaj, a seasoned investment and private equity professional with degrees from the University of Pennsylvania and Harvard University, brings substantial expertise in finance, strategy, and corporate governance, which is expected to strengthen Indegene’s board oversight and strategic direction as it scales its healthcare and life sciences services business. The board also cleared the allotment of 149,635 shares under the company’s ESOP 2020 and RSU 2020 plans, signaling continued use of equity-based incentives to attract and retain key talent.
More about Indegene Limited
Indegene Limited is a Bengaluru-based company operating in the healthcare and life sciences services space, providing technology-enabled solutions and platforms to global pharmaceutical and healthcare organizations. Listed on Indian stock exchanges, it focuses on delivering specialized services that support clients’ commercial, medical, and regulatory operations worldwide.
Average Trading Volume: 13,896
Technical Sentiment Signal: Sell
Current Market Cap: 127.5B INR
See more data about INDGN stock on TipRanks’ Stock Analysis page.